Opinion

Video

Moving Beyond the Joint: The Interplay between Gout and Kidney Disease 

Author(s):

Nehad Soloman, MD, FACRAndrew Sharobeem, DO, FACR

Nehad Soloman, MD, FACR; Andrew Sharobeem, DO, FACR, and Sunil Patel, MD, explore the nephrologist's vital role in gout diagnosis, treatment options for gout patients with chronic kidney disease, and strategies for managing refractory gout and its associated challenges.

Related Videos
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Comparing Treatment Options for Psoriatic Arthritis with Philip Mease, MD
Related Content
Ophthalmology Month in Review: September 2024 | Image Credit: HCPLive
October 8th 2024

Ophthalmology Month in Review: September 2024

Connor Iapoce
Taher Modarressi, MD | Credit: X.com
October 3rd 2024

Don't Miss a Beat: Putting Evidence-Based Cardiometabolic Therapies into Practice, with Taher Modarressi, MD

Muthiah Vaduganathan, MD, MPH Stephen Greene, MD
Pam Taub, MD | Credit: UC San Diego Health
October 8th 2024

Time-Restricted Eating Shows Promise for Metabolic Syndrome in 3-Month Trial

Patrick Campbell
MEDCast Podcast logo
October 1st 2024

Exploring Oral Systemic Therapies for Plaque Psoriasis: Efficacy, Safety, and Clinical Considerations

Lauren Miller, MPAS, PA-C Jayme M Heim, MSN, FNP-BC Kirk Gautier, PA-C
Allergy Month in Review: September 2024
October 8th 2024

Allergy Month in Review: September 2024

Tim Smith
Ixekizumab as Effective, if not More Effective as TNFi, JAKi, IL-12/23i for PsA Treatment
October 8th 2024

Ixekizumab as Effective, if not More Effective as TNFi, JAKi, IL-12/23i for PsA Treatment

Victoria Johnson
© 2024 MJH Life Sciences

All rights reserved.